Dr. Lichter Discusses the Growing Concern for the Future of Oncology Practice if the SGR is Not Fixed
February 13, 2012
In this final segment, Dr. Allen Lichter, CEO of ASCO, discusses the impact SGR has on patients. If a solution cannot be found, Dr. Lichter says that it will be devastating to oncology care. “We are in this together, and want to work together not only as an oncology field, but as a member of the larger community, of medicine and specialty societies to solve this problem,” says Dr. Lichter.